is there a shortage of glp 1 drugs Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s The GLP-1 shortage is real.

Moderate changes of the K m app values in combination with the altered k cat app values resulted in decreased apparent catalytic efficiencies of E170A/K for both substrates as compared with the wild-type enzyme and E170D (Fig

By comparison, the same paper estimated that reductions in systolic blood pressure were responsible for 53%, while smoking cessation accounted for 13%, and 5% was attributable to increased physical activity

Medicare Part D Gross Spending on GLP-1s Increased Five-Fold Between 2019 and 2024, But Estimated Rebates of Around 50% Mean That Net Spending is Much Lower Gross Medicare Part D spending on GLP-1s in 2024 (not accounting for rebates) totaled $27.5 billion, a five-fold increase from 2019, reflecting an expansion in use of GLP-1s with more recent FDA approvals for type 2 diabetes

10.1016/j.cell.2016.02.014 43 JangY.-Y.SharkisS